90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Saved in:
Bibliographic Details
Title: 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Authors: Janik JE; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Morris JC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, O'Mahony D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Redon CE; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Bonner WM; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Brechbiel MW; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Paik CH; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Whatley M; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Chen C; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Lee JH; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Fleisher TA; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Brown M; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, White JD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Stewart DM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Fioravanti S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Lee CC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Goldman CK; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Bryant BR; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Junghans RP; Department of Medicine, Roger Williams Medical Center, Providence, RI 02908., Carrasquillo JA; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Worthy T; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Corcoran E; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Conlon KC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tawald@helix.nih.gov.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2015 Oct 20; Vol. 112 (42), pp. 13045-50. Date of Electronic Publication: 2015 Oct 05.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26438866
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Janik+JE%22">Janik JE</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Morris+JC%22">Morris JC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22O'Mahony+D%22">O'Mahony D</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Pittaluga+S%22">Pittaluga S</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Jaffe+ES%22">Jaffe ES</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Redon+CE%22">Redon CE</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Bonner+WM%22">Bonner WM</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Brechbiel+MW%22">Brechbiel MW</searchLink>; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Paik+CH%22">Paik CH</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Whatley+M%22">Whatley M</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Fleisher+TA%22">Fleisher TA</searchLink>; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22White+JD%22">White JD</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Stewart+DM%22">Stewart DM</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Fioravanti+S%22">Fioravanti S</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Lee+CC%22">Lee CC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Goldman+CK%22">Goldman CK</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Bryant+BR%22">Bryant BR</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Junghans+RP%22">Junghans RP</searchLink>; Department of Medicine, Roger Williams Medical Center, Providence, RI 02908.<br /><searchLink fieldCode="AU" term="%22Carrasquillo+JA%22">Carrasquillo JA</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Worthy+T%22">Worthy T</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Corcoran+E%22">Corcoran E</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Conlon+KC%22">Conlon KC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Waldmann+TA%22">Waldmann TA</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tawald@helix.nih.gov.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2015 Oct 20; Vol. 112 (42), pp. 13045-50. <i>Date of Electronic Publication: </i>2015 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26438866
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1073/pnas.1516107112
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 13045
    Titles:
      – TitleFull: 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janik JE
      – PersonEntity:
          Name:
            NameFull: Morris JC
      – PersonEntity:
          Name:
            NameFull: O'Mahony D
      – PersonEntity:
          Name:
            NameFull: Pittaluga S
      – PersonEntity:
          Name:
            NameFull: Jaffe ES
      – PersonEntity:
          Name:
            NameFull: Redon CE
      – PersonEntity:
          Name:
            NameFull: Bonner WM
      – PersonEntity:
          Name:
            NameFull: Brechbiel MW
      – PersonEntity:
          Name:
            NameFull: Paik CH
      – PersonEntity:
          Name:
            NameFull: Whatley M
      – PersonEntity:
          Name:
            NameFull: Chen C
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Fleisher TA
      – PersonEntity:
          Name:
            NameFull: Brown M
      – PersonEntity:
          Name:
            NameFull: White JD
      – PersonEntity:
          Name:
            NameFull: Stewart DM
      – PersonEntity:
          Name:
            NameFull: Fioravanti S
      – PersonEntity:
          Name:
            NameFull: Lee CC
      – PersonEntity:
          Name:
            NameFull: Goldman CK
      – PersonEntity:
          Name:
            NameFull: Bryant BR
      – PersonEntity:
          Name:
            NameFull: Junghans RP
      – PersonEntity:
          Name:
            NameFull: Carrasquillo JA
      – PersonEntity:
          Name:
            NameFull: Worthy T
      – PersonEntity:
          Name:
            NameFull: Corcoran E
      – PersonEntity:
          Name:
            NameFull: Conlon KC
      – PersonEntity:
          Name:
            NameFull: Waldmann TA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 10
              Text: 2015 Oct 20
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1091-6490
          Numbering:
            – Type: volume
              Value: 112
            – Type: issue
              Value: 42
          Titles:
            – TitleFull: Proceedings of the National Academy of Sciences of the United States of America
              Type: main
ResultId 1